University of Cincinnati
Cincinnati, Ohio, 45267-0559, United States
NCT Number: NCT00608296
The purpose of the research is to study brain structure, function and chemistry of patients with bipolar disorder who are receiving quetiapine or lithium, in order to better understand who benefits from treatment and why they respond to medications.
Looking for future studies?
Notify Me12 year–35 year
All sexes
Observational
Cincinnati, Ohio, 45267-0559, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Depressed bipolar patients (N=100; 15-20 patients/year):
Exclusion criteria
All subjects will be excluded from participation for the following reasons:
University of Cincinnati
Other
Functional and Neurochemical Brain Changes Following Successful Treatment of Early Course Bipolar Depression
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04121091
Anhedonia, Bipolar Disorder
Lund, Sweden
View Trial DetailsNCT05436613
Bipolar Disorder, Bipolar and Related Disorders
London, United Kingdom
View Trial DetailsNCT03538275
Bipolar Disorder, Bipolar and Related Disorders
Rochester, Minnesota, United States
View Trial DetailsNCT04701866
Bipolar Disorder, Bipolar and Related Disorders
Montreal, Quebec, Canada
View Trial Details